Kenvue Ribbon-Cutting Marks Official Opening of New Global Headquarters in Summit, New Jersey

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Positive)

Tags

03/19/2025 - 06:45 AM

Maker of iconic brands such as Neutrogena^®, Listerine^®, Aveeno^®, and Tylenol^® embarks on new era at global headquarters in 2025

SUMMIT, N.J.--(BUSINESS WIRE)-- Today, Kenvue Inc. (NYSE: KVUE) held a ribbon-cutting ceremony for its new 290,000 sq. ft. global headquarters in Summit, New Jersey. The Company – which marked the start of construction of its 100,000 sq. ft. state-of-the-art Science and Innovation Lab at a ceremony last year – has officially moved its headquarters from Skillman to Summit, New Jersey.

Kenvue Global Headquarters, Summit, N.J.

Locating its LEED Gold certified global headquarters in Summit, New Jersey offers Kenvue the opportunity to foster a collaborative environment where teams previously spread across seven geographic locations across the U.S. can come together and take advantage of the new spaces designed to accelerate innovation, and enhance consumer experiences:

The Insights Lab, a high-tech, multi-room experience is designed to transform how Kenvue develops, tests, and showcases its products. The Virtual Experience Room immerses users in a 270-degree digital retail environment, allowing real-time feedback on in-store execution.
The Sensory Lab enables rapid prototyping and consumer testing, ensuring products meet evolving consumer needs.
The Design Lab brings human-centered design to life through advanced 3D and 2D modeling.
At the heart of the headquarters, The Company Store offers a best-in-class shopping experience, turning every Kenvuer into a brand ambassador.

The new headquarters also provides the Company with proximity to exceptional talent across major areas, such as life science, data, technology, and marketing, which is crucial for a people-first company like Kenvue. Joined by New Jersey Governor Phil Murphy, Summit Mayor Elizabeth Fagan, MD, and other state and local officials, Kenvue Chief Executive Officer, Thibaut Mongon, underscored the Company’s commitment to innovation in the State of New Jersey and delivering the future of consumer health. Kenvue also welcomed New Jersey-based charitable partners, including its newly announced local community partners, Bridges Outreach and GRACE.

“There is no better place to unlock the full potential of our iconic brands than in the state many of our brands have proudly called home for more than 135 years,” said Thibaut Mongon, Chief Executive Officer, Kenvue. “Our thoughtfully designed campus, brings together our iconic brands and our people under one roof, allowing us to innovate, drive growth and realize the extraordinary power of everyday care for more people in New Jersey and around the world.”

“I am thrilled to welcome Kenvue as they establish their home in Summit, cementing the company’s commitment to building the future of consumer health right here in the Garden State,” said New Jersey Governor Phil Murphy. “This new headquarters exemplifies my Administration’s commitment to making New Jersey a destination for world-class companies that are driving innovation.”

“Today marks a significant milestone for Summit as we celebrate the ribbon cutting of Kenvue global headquarters. Their commitment to innovation and excellence not only enriches our community but also positions Summit as a hub for cutting-edge advancements in consumer health,” stated Summit Mayor Elizabeth Fagan, MD. “We are excited to welcome Kenvue to our city and look forward to the positive impact they will have on our residents and beyond.”

For his part, U.S. Rep. Tom Kean touched on the importance of innovation, “Boosting innovation at home is incredibly important and New Jersey’s reputation as a leader in this space continues to grow by welcoming Kenvue’s global headquarters and research hub to Summit. The cutting-edge work done here will benefit families across our country and fuel the local economy here in Union County.”

By combining the power of science with meaningful human insights and a digital-first approach, Kenvue is poised to lead the charge in redefining consumer health for the future with science-driven innovations for iconic brands such as Neutrogena^®, Listerine^®, Tylenol^® and Aveeno^®amplified by cutting-edge technology, sustainable design and state-of-the-art amenities.

About Kenvue

Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno^®, BAND-AID^® Brand, Johnson’s^®, Listerine^®, Neutrogena^®, and Tylenol^®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Cautions Concerning Forward-Looking Statements

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the opening of Kenvue’s new global headquarters in Summit, New Jersey. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates.

A list and descriptions of risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.